Low TP53 variant allele frequency as a biomarker for anti-programmed death (ligand) 1 monotherapy in lung adenocarcinoma.
Shou-Zheng WangTongji XieYan LiLei GuoJian-Ming YingYan WangXuezhi HaoXingyuan WangJunling LiPuyuan XingPublished in: Cancer (2023)
T cells.